INTERNATIONAL PATENT: GLUGENETHERAPEUTICS INC., 주식회사 글루진테라퓨틱스 FILES APPLICATION FOR "ADENO-ASSOCIATED VIRUS VECTOR CAPABLE OF DELIVERING ASTROCYTE-SPECIFIC GENE"

GENEVA, May 19 -- GLUGENETHERAPEUTICS INC. (3rd Floor, 65-1, Techno 8-roYuseong-guDaejeon 34028), 주식회사 글루진테라퓨틱스 (대전광역시유성구테크노8로 65-1, 3층) filed a patent application (PCT/KR2024/017566) for "ADENO-ASSOCIATED VIRUS VECTOR CAPABLE OF DELIVERING ASTROCYTE-SPECIFIC GENE" on Nov 08, 2024. With publication no. WO/2025/100977, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO)...